Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers.

Vasen HF, van Ballegooijen M, Buskens E, Kleibeuker JK, Taal BG, Griffioen G, Nagengast FM, Menko FH, Meera Khan P.

Cancer. 1998 May 1;82(9):1632-7.

PMID:
9576281
[PubMed - indexed for MEDLINE]
2.

Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness.

Reyes CM, Allen BA, Terdiman JP, Wilson LS.

Cancer. 2002 Nov 1;95(9):1848-56.

PMID:
12404277
[PubMed - indexed for MEDLINE]
Free Article
3.

Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.

Bonis PA, Trikalinos TA, Chung M, Chew P, Ip S, DeVine DA, Lau J.

Evid Rep Technol Assess (Full Rep). 2007 May;(150):1-180. Review.

PMID:
17764220
[PubMed - indexed for MEDLINE]
Free Article
4.

Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations.

Syngal S, Weeks JC, Schrag D, Garber JE, Kuntz KM.

Ann Intern Med. 1998 Nov 15;129(10):787-96.

PMID:
9841584
[PubMed - indexed for MEDLINE]
5.

Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures.

Wagner A, van Kessel I, Kriege MG, Tops CM, Wijnen JT, Vasen HF, van der Meer CA, van Oostrom II, Meijers-Heijboer H.

Fam Cancer. 2005;4(4):295-300.

PMID:
16341806
[PubMed - indexed for MEDLINE]
6.

Predictive genetic testing of first degree relatives of mutation carriers is a cost-effective strategy in preventing hereditary non-polyposis colorectal cancer in Singapore.

Wang VW, Koh PK, Chow WL, Lim JF.

Fam Cancer. 2012 Jun;11(2):279-89. doi: 10.1007/s10689-012-9513-y.

PMID:
22350504
[PubMed - indexed for MEDLINE]
7.

Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer.

Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N.

Ann Intern Med. 2001 Oct 16;135(8 Pt 1):577-88.

PMID:
11601929
[PubMed - indexed for MEDLINE]
8.

Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families.

de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G, Menko FH, Taal BG, Kleibeuker JH, Vasen HF.

Dis Colon Rectum. 2002 Dec;45(12):1588-94.

PMID:
12473880
[PubMed - indexed for MEDLINE]
9.

What is the appropriate screening protocol in Lynch syndrome?

de Jong AE, Nagengast FM, Kleibeuker JH, van de Meeberg PC, van Wijk HJ, Cats A, Griffioen G, Vasen HF.

Fam Cancer. 2006;5(4):373-8. Epub 2006 Jul 7.

PMID:
16826316
[PubMed - indexed for MEDLINE]
10.

[Prevention of colorectal cancer in families with hereditary nonpolyposis colorectal cancer].

Bernstein IT, Bisgaard ML, Myrhøj T.

Ugeskr Laeger. 2003 Jan 13;165(3):221-5. Danish.

PMID:
12555703
[PubMed - indexed for MEDLINE]
11.

Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome.

Mecklin JP, Aarnio M, Läärä E, Kairaluoma MV, Pylvänäinen K, Peltomäki P, Aaltonen LA, Järvinen HJ.

Gastroenterology. 2007 Oct;133(4):1093-8. Epub 2007 Aug 14.

PMID:
17919485
[PubMed - indexed for MEDLINE]
12.

Clinical identification and long-term surveillance of 22 hereditary non-polyposis colon cancer Italian families.

Arrigoni A, Sprujevnik T, Alvisi V, Rossi A, Ricci G, Pennazio M, Spandre M, Cavallero M, Bertone A, Foco A, Rossini FP.

Eur J Gastroenterol Hepatol. 2005 Feb;17(2):213-9.

PMID:
15674100
[PubMed - indexed for MEDLINE]
13.

Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.

Järvinen HJ, Renkonen-Sinisalo L, Aktán-Collán K, Peltomäki P, Aaltonen LA, Mecklin JP.

J Clin Oncol. 2009 Oct 1;27(28):4793-7. doi: 10.1200/JCO.2009.23.7784. Epub 2009 Aug 31.

PMID:
19720893
[PubMed - indexed for MEDLINE]
Free Article
14.

Surveillance colonoscopy in individuals at risk for hereditary nonpolyposis colorectal cancer: an evidence-based review.

Johnson PM, Gallinger S, McLeod RS.

Dis Colon Rectum. 2006 Jan;49(1):80-93; discussion 94-5.

PMID:
16284887
[PubMed - indexed for MEDLINE]
15.

Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect.

de Vos tot Nederveen Cappel WH, Buskens E, van Duijvendijk P, Cats A, Menko FH, Griffioen G, Slors JF, Nagengast FM, Kleibeuker JH, Vasen HF.

Gut. 2003 Dec;52(12):1752-5.

PMID:
14633956
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Clinical features and mismatch repair genes analyses of Chinese suspected hereditary non-polyposis colorectal cancer: a cost-effective screening strategy proposal.

Yan HL, Hao LQ, Jin HY, Xing QH, Xue G, Mei Q, He J, He L, Sun SH.

Cancer Sci. 2008 Apr;99(4):770-80. doi: 10.1111/j.1349-7006.2008.00737.x. Epub 2008 Feb 27.

PMID:
18307539
[PubMed - indexed for MEDLINE]
17.

Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families.

Vasen HF, Taal BG, Nagengast FM, Griffioen G, Menko FH, Kleibeuker JH, Offerhaus GJ, Meera Khan P.

Eur J Cancer. 1995 Jul-Aug;31A(7-8):1145-8.

PMID:
7577010
[PubMed - indexed for MEDLINE]
18.

Cost-effectiveness of surveillance programs for families at high and moderate risk of hereditary non-polyposis colorectal cancer.

Olsen KR, Bojesen SE, Gerdes AM, Lindorff-Larsen K, Bernstein IT.

Int J Technol Assess Health Care. 2007 Winter;23(1):89-95.

PMID:
17234021
[PubMed - indexed for MEDLINE]
19.

The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC.

De Jong AE, Morreau H, Van Puijenbroek M, Eilers PH, Wijnen J, Nagengast FM, Griffioen G, Cats A, Menko FH, Kleibeuker JH, Vasen HF.

Gastroenterology. 2004 Jan;126(1):42-8.

PMID:
14699485
[PubMed - indexed for MEDLINE]
20.

Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer.

Engel C, Rahner N, Schulmann K, Holinski-Feder E, Goecke TO, Schackert HK, Kloor M, Steinke V, Vogelsang H, Möslein G, Görgens H, Dechant S, von Knebel Doeberitz M, Rüschoff J, Friedrichs N, Büttner R, Loeffler M, Propping P, Schmiegel W; German HNPCC Consortium.

Clin Gastroenterol Hepatol. 2010 Feb;8(2):174-82. doi: 10.1016/j.cgh.2009.10.003. Epub 2009 Oct 14.

PMID:
19835992
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk